TTYH2 inhibitors are a class of chemical compounds designed to target and inhibit the activity of the Tweety homolog 2 (TTYH2) protein, which belongs to the Tweety family of chloride ion channels. TTYH2 is a transmembrane protein involved in the regulation of ion transport across the cell membrane, particularly chloride ions, which play a critical role in maintaining cellular homeostasis, osmotic balance, and signal transduction. TTYH2 is expressed in various tissues and is believed to participate in processes like cell volume regulation and chloride ion efflux. By inhibiting TTYH2, these compounds disrupt chloride ion flow, thereby altering the cellular ionic environment and influencing related physiological processes.
Structurally, TTYH2 inhibitors typically interact with specific regions of the protein, such as the transmembrane domains responsible for forming the ion-conducting pore. These inhibitors may block chloride ion binding or prevent the channel from opening, effectively reducing chloride transport across the membrane. By inhibiting TTYH2, researchers can gain insights into the protein's role in cellular ionic balance and its contribution to the regulation of various cellular activities such as signal transduction, cell proliferation, and volume regulation. TTYH2 inhibitors serve as valuable tools for investigating the mechanisms of chloride channel regulation and the broader implications of ion channel activity in cell physiology. Their use helps to elucidate the specific roles of TTYH2 in maintaining the delicate balance of ions that underpins many essential cellular functions.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Inhibits protein kinases potentially regulating TTYH2 phosphorylation, altering its function. | ||||||
BAPTA/AM | 126150-97-8 | sc-202488 sc-202488A | 25 mg 100 mg | $138.00 $458.00 | 61 | |
Chelates calcium, leading to reduced calcium signaling that may affect TTYH2-dependent processes. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Inhibits tyrosine kinases which could modulate TTYH2 through tyrosine phosphorylation regulation. | ||||||
W-7 | 61714-27-0 | sc-201501 sc-201501A sc-201501B | 50 mg 100 mg 1 g | $166.00 $306.00 $1675.00 | 18 | |
Calmodulin antagonist that may alter TTYH2 function by disrupting calcium/calmodulin-dependent signaling. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
Inhibits MEK, which may affect TTYH2 activity by altering ERK/MAPK signaling pathways. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
PI3K inhibitor, which may impact TTYH2 function by modulating the PI3K/AKT pathway. | ||||||
2-Deoxy-D-glucose | 154-17-6 | sc-202010 sc-202010A | 1 g 5 g | $70.00 $215.00 | 26 | |
Inhibits glycolysis, potentially affecting TTYH2 function by altering cellular energy levels. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Disrupts calcium storage, potentially altering TTYH2 activity by modifying calcium homeostasis. | ||||||
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $172.00 $305.00 | 66 | |
Blocks N-linked glycosylation, potentially affecting TTYH2 function if it is glycosylation-dependent. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
mTOR inhibitor that may decrease TTYH2 synthesis or increase its degradation by affecting protein synthesis pathways. | ||||||